Waystar (NASDAQ:WAY) Stock Price Target Raised at Truist Financial

Key Points

• Truist Financial raised its Waystar price target to $35 from $33 and maintained a Buy rating, implying 21.55% upside from the prior close.
• Waystar shares rose 4.1% to $28.79 on Wednesday. Analysts’ average rating is Moderate Buy, with an average price target of $35.23.
• The company beat quarterly expectations, reporting EPS of $0.44 versus $0.41 expected and revenue of $325.62 million versus $323.43 million; revenue grew 21.2% year over year.

Waystar (NASDAQ:WAY - Get Free Report) had its price objective hoisted by research analysts at Truist Financial from $33.00 to $35.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. Truist Financial's price target would indicate a potential upside of 21.55% from the stock's previous close.

WAY has been the subject of a number of other reports. KeyCorp lifted their price target on Waystar from $30.00 to $35.00 and gave the stock an "overweight" rating in a research note on Friday, October 16th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $39.00 price objective on shares of Waystar in a research note on Friday, July 31st. Wells Fargo & Company reduced their target price on Waystar from $36.00 to $33.00 and set an "overweight" rating on the stock in a report on Thursday, July 30th. Canaccord Genuity Group lifted their target price on Waystar from $33.00 to $34.00 and gave the stock a "buy" rating in a research report on Tuesday. Finally, Citigroup reiterated a "buy" rating on shares of Waystar in a report on Monday, July 20th. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Waystar currently has an average rating of "Moderate Buy" and an average target price of $35.23.

Waystar Stock Up 4.1%

NASDAQ WAY traded up $1.13 during trading hours on Wednesday, reaching $28.79. 1,286,225 shares of the company traded hands, compared to its average volume of 2,540,703. Waystar has a 12 month low of $17.26 and a 12 month high of $37.51. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $5.52 billion, a PE ratio of 41.78, a PEG ratio of 1.10 and a beta of 0.11. The company has a 50 day moving average of $26.27 and a two-hundred day moving average of $23.96.

Waystar (NASDAQ:WAY - Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.03. The company had revenue of $325.62 million during the quarter, compared to the consensus estimate of $323.43 million. Waystar had a net margin of 10.70% and a return on equity of 6.95%. The company's revenue was up 21.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.37 EPS. As a group, equities analysts expect that Waystar will post 1.47 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Matthew Hawkins sold 82,500 shares of the firm's stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $26.23, for a total transaction of $2,163,975.00. Following the transaction, the chief executive officer directly owned 1,804,794 shares of the company's stock, valued at approximately $47,339,746.62. This trade represents a 4.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 247,500 shares of company stock worth $6,370,499. 3.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Waystar

Several hedge funds have recently made changes to their positions in the business. Canada Pension Plan Investment Board acquired a new stake in shares of Waystar in the second quarter worth $390,593,000. BlackRock Inc. bought a new stake in shares of Waystar in the 2nd quarter valued at approximately $357,950,000. Advent International L.P. acquired a new stake in Waystar in the second quarter valued at approximately $227,060,000. Jupiter Topco LLC acquired a new position in shares of Waystar during the 2nd quarter worth $58,960,000. Finally, Bank of America Corp DE acquired a new position in Waystar during the second quarter worth $53,031,000.

Trending Headlines about Waystar

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Waystar reported Q3 revenue of $325.6 million, up 21% year over year, and adjusted EPS of $0.44, topping estimates of $323.4 million and $0.41, respectively. Adjusted EBITDA margin was 43%. Waystar Reports Third Quarter 2026 Results
• Positive Sentiment: Deutsche Bank raised its price target to $42 from $39 and maintained a Buy rating, signaling continued analyst confidence. Deutsche Bank Raises Price Target on Waystar
• Positive Sentiment: RBC Capital Markets cited solid leading indicators and expects them to convert into revenue in 2027, supporting the longer-term growth outlook. RBC Capital Markets on Waystar’s Leading Indicators
• Positive Sentiment: Canaccord Genuity raised its price target to $34 from $33 and kept its Buy rating. Canaccord Genuity recommendations
• Neutral Sentiment: Waystar’s 2026 EPS guidance of $1.63–$1.71 is in line with or above the $1.63 consensus, and the company raised its adjusted EBITDA outlook to $543–$549 million. However, its $1.277–$1.287 billion revenue forecast is below the roughly $1.3 billion consensus. Waystar updates 2026 outlook
• Neutral Sentiment: TD Cowen cut its price target to $39 from $42 but retained a Buy rating, making the analyst revisions mixed overall. TD Cowen recommendations

Waystar Company Profile

Waystar Holding Corp. is a healthcare technology company that provides cloud-based software designed to simplify administrative and financial processes across the healthcare industry. Its platform connects healthcare providers, health plans and patients, helping organizations manage revenue cycle operations and improve the flow of information and payments.

The company's products and services include electronic claims management, eligibility and benefits verification, prior authorization, payment integrity, denial management, patient estimates and payments, billing automation, and healthcare analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.